2022年2月3日简报:南非奥密克戎亚型变异株BA.2正快速传播;以色列出现第一批感染奥密克戎康复后再次感染其亚型毒株BA.2病例;日本新增病例9万,政府认为不需要进入紧急状态

2022-02-03 MedSci整理 MedSci整理

截至北京时间2022年2月3日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过3亿8507万例,新增3,002,469例,达到385,075,

截至北京时间2022年2月3日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎COVID-19)病例超过3亿8507万例,新增3,002,469例,达到385,075,439例。累计死亡病例571.7万例,达到5,717,731例。新增死亡为11,609例。康复为305,008,540例,重症和危重症病人达到91,846例;全球新冠确诊病例超过100万例的国家达50个,120个国家病例超10万例。昨日报道:2022年2月2日简报:张文宏认为最坏的日子要慢慢过去啦;美国因新冠死亡人数接近100万,八成是老人;全球因抗击疫情产生了海量医疗垃圾,威胁环境与人类健康

以色列出现第一批感染奥密克戎康复后再次感染其亚型毒株BA.2病例

据以色列Kan News报道,随着奥密克戎变异毒株继续传播,以色列出现了第一批感染奥密克戎康复者再次感染其更具传染性的亚型毒株BA.2的病例。

以色列卫生部在从国外回以色列的人群中发现了超过350个这种病例,其中大多数人此前已经在以色列被感染。新的亚型毒株被认为能引起与奥密克戎原始毒株相同程度的严重疾病。

世界各地已经记录了越来越多从感染奥密克戎后康复的人群再次被BA.2毒株感染的案例。

以色列卫生机构表示,对这一现象的临床意义仍不清楚。目前还不清楚这些病例是否发生在接种过疫苗的人当中,是否与他们的免疫系统强度有关,以及是否会根据他们接触的病毒载量产生影响。

科学家们还不知道在感染奥密克戎的人群中形成的抗体是否能中和BA.2毒株引起的疾病。如果发现抗体无效,这意味着可能会延长奥密克戎疫情的持续时间,甚至导致病例数再次上升。

全球首个“让人类故意感染新冠病毒”的试验被证明是安全的

据英国媒体报道,在疫情爆发初期,一些研究人员就曾呼吁使用一种确定某种新冠疫苗是否有效的快速方法,即让接种的志愿者主动感染病毒,并推进对新冠病毒及其导致的新冠肺炎进一步研究。

当地时间2月2日,负责开展世界上首个人类挑战试验的研究团队表示,该试验对健康的年轻人是安全的。

爱尔兰制药公司Open Orphan与英国伦敦帝国理工学院、英国政府的疫苗工作组和临床公司hVIVO共同开展了这项为期一年的项目。

该试验使36名18-29岁的健康男性和女性志愿者感染了新冠病毒原始毒株,并在受控的隔离环境下对他们进行密切监测。他们从隔离设施出院后将被随访12个月。

研究人员表示,没有发现严重的不良事件,人类挑战研究模型被证明在健康的年轻成年人中是 "安全和耐受性良好的"。

这将意味着新冠病毒人体挑战研究可以在2022年进行,但需要得到个别伦理和监管部门的批准。

日本新增病例9万 日政府:目前不需要进入紧急状态

据日本放送协会(NHK)消息,截至到当地时间2月2日23时59分,日本报告新增新冠肺炎确诊病例94930例,较前一日增加了13000多例,首次突破9万例;新增相关死亡病例82例,创历史新高。

东京在过去24小时新增21567例确诊病例。感染的迅速蔓延导致在家中和设施中的感染者,以及在家中和隔夜护理中的治疗者人数创下新高。 一位市政府官员说,任何人都可能成为感染者或与他人密切接触的人,并敦促采取彻底的措施来预防感染。

截至目前,日本累计确诊病例2921177例,累计死亡18980例。

日本政府密切关注新冠肺炎患者的医院床位使用率。目前,这个比率已上升至51.4%。官员之前表示,如果使用率达到50%,就需要进入紧急状态,但他们现在认为,该决定将取决于严重病例数量和其他因素。

北京:奥密克戎关联疫情基本控制

北京市疾控中心副主任刘晓峰在2月2日的新闻发布会上介绍,1月15日以来,本市累计报告本土新冠肺炎病毒感染者115例,其中,奥密克戎变异株关联疫情累计报告病例6例,均为确诊病例,均为轻型,已连续10日无新增感染者报告,自全面管控之日起已达14天,疫情已基本得到控制。

杭州:节后中高风险地区所在县市区人员限制跨省出行

杭州市政府副秘书长毛根洪在2日举行的市疫情防控工作新闻发布会上表示,无疫情省份人员可正常返杭,无需任何证明。省内有疫情发生的,需持48小时内核酸阴性证明返杭。中高风险地区返杭人员,将实行“14+7”健康管理措施;中高风险地区所在镇、街道或公布的划定范围返杭人员实行“2+14”健康管理措施。

节后出杭政策方面,毛根洪表示,为防止风险外溢,中高风险地区所在县市区人员,限制跨省出行;其他县市区人员离杭需持48小时核酸阴性证明。

白宫警告:奥密克戎疫情可能冲击非农数据

据当地媒体报道,多位白宫高级官员对即将在周五公布的非农就业报告给出悲观预期,表示1月报告进行调查的时候,恰好与假日季后疫情高峰导致的大量病休重合,可能会“夸大”1月非农中的失业数字。

就在周三发稿前不久,刚刚公布的ADP美国1月私营部门就业数字意外下降30万人,市场预期增加20万人,对疫情最敏感的休闲和接待产业大幅减少15.4万人就业岗位

南非研究人员:奥密克戎亚型变异株BA.2正快速传播

据媒体周三报道,南非斯泰伦博斯大学生物信息学教授Tulio de Oliveira在发布会上表示,奥密克戎亚型变异株BA.2正在该国快速传播,可能会造成本轮疫情再度拉升。Tulio教授表示,这意味着奥密克戎疫情感染数字最终可能形成“驼峰”式的曲线,即一轮疫情平息后再度拉升。

研究显示BA.2似乎比最初的omicron变种传染性更强,因此引起了人们的担忧。南非和博茨瓦纳于去年11月最先宣布发现了omicron变异毒株。

研究还显示,轻度感染两种omicron毒株中的任何一种,可能都无法产生足够强的免疫反应来抵御再一次感染omicron毒株。从丹麦和英国的感染病例激增来看,没有迹象表明BA.2亚种会导致更严重的疾病。

omicron感染浪潮“最终可能像驼峰一样” ,负责管理基因测序机构并为疫情向政府提供咨询的生物信息学教授Tulio de Oliveira周三在斯泰伦博斯大学的一次讲座中表示。 “一波又一波。”

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1924221, encodeId=a5b819242219d, content=<a href='/topic/show?id=a37158322eb' target=_blank style='color:#2F92EE;'>#新增病例#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58322, encryptionId=a37158322eb, topicName=新增病例)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/xkicoVBAnV4HxvdCqC1viaW8wdLQdN9hVP9icgqqDsxC6UVPjfhogdfc2iaU1xNUMVlFl5QicicWrjWQBTsVye5ngOQQ/132, createdBy=f92f2500185, createdName=ms7405317358118777, createdTime=Fri Oct 07 20:24:30 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1294653, encodeId=7998129465388, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59218, encryptionId=ca6e592189b, topicName=日本)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Sat Feb 05 00:24:30 CST 2022, time=2022-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342961, encodeId=ae561342961b7, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Sat Feb 05 00:24:30 CST 2022, time=2022-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1414481, encodeId=113414144813e, content=<a href='/topic/show?id=8e95364321f' target=_blank style='color:#2F92EE;'>#南非#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36432, encryptionId=8e95364321f, topicName=南非)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83403055912, createdName=hongbochen, createdTime=Sat Feb 05 00:24:30 CST 2022, time=2022-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1523376, encodeId=687315233e688, content=<a href='/topic/show?id=1a1de7006b0' target=_blank style='color:#2F92EE;'>#紧急#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77006, encryptionId=1a1de7006b0, topicName=紧急)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b88211514540, createdName=guguangxiang, createdTime=Sat Feb 05 00:24:30 CST 2022, time=2022-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189855, encodeId=4be311898550e, content=未来象感冒一样,每隔一段时间就会再次有感染可能, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Thu Feb 03 10:26:43 CST 2022, time=2022-02-03, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1924221, encodeId=a5b819242219d, content=<a href='/topic/show?id=a37158322eb' target=_blank style='color:#2F92EE;'>#新增病例#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58322, encryptionId=a37158322eb, topicName=新增病例)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/xkicoVBAnV4HxvdCqC1viaW8wdLQdN9hVP9icgqqDsxC6UVPjfhogdfc2iaU1xNUMVlFl5QicicWrjWQBTsVye5ngOQQ/132, createdBy=f92f2500185, createdName=ms7405317358118777, createdTime=Fri Oct 07 20:24:30 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1294653, encodeId=7998129465388, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59218, encryptionId=ca6e592189b, topicName=日本)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Sat Feb 05 00:24:30 CST 2022, time=2022-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342961, encodeId=ae561342961b7, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Sat Feb 05 00:24:30 CST 2022, time=2022-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1414481, encodeId=113414144813e, content=<a href='/topic/show?id=8e95364321f' target=_blank style='color:#2F92EE;'>#南非#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36432, encryptionId=8e95364321f, topicName=南非)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83403055912, createdName=hongbochen, createdTime=Sat Feb 05 00:24:30 CST 2022, time=2022-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1523376, encodeId=687315233e688, content=<a href='/topic/show?id=1a1de7006b0' target=_blank style='color:#2F92EE;'>#紧急#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77006, encryptionId=1a1de7006b0, topicName=紧急)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b88211514540, createdName=guguangxiang, createdTime=Sat Feb 05 00:24:30 CST 2022, time=2022-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189855, encodeId=4be311898550e, content=未来象感冒一样,每隔一段时间就会再次有感染可能, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Thu Feb 03 10:26:43 CST 2022, time=2022-02-03, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1924221, encodeId=a5b819242219d, content=<a href='/topic/show?id=a37158322eb' target=_blank style='color:#2F92EE;'>#新增病例#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58322, encryptionId=a37158322eb, topicName=新增病例)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/xkicoVBAnV4HxvdCqC1viaW8wdLQdN9hVP9icgqqDsxC6UVPjfhogdfc2iaU1xNUMVlFl5QicicWrjWQBTsVye5ngOQQ/132, createdBy=f92f2500185, createdName=ms7405317358118777, createdTime=Fri Oct 07 20:24:30 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1294653, encodeId=7998129465388, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59218, encryptionId=ca6e592189b, topicName=日本)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Sat Feb 05 00:24:30 CST 2022, time=2022-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342961, encodeId=ae561342961b7, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Sat Feb 05 00:24:30 CST 2022, time=2022-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1414481, encodeId=113414144813e, content=<a href='/topic/show?id=8e95364321f' target=_blank style='color:#2F92EE;'>#南非#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36432, encryptionId=8e95364321f, topicName=南非)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83403055912, createdName=hongbochen, createdTime=Sat Feb 05 00:24:30 CST 2022, time=2022-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1523376, encodeId=687315233e688, content=<a href='/topic/show?id=1a1de7006b0' target=_blank style='color:#2F92EE;'>#紧急#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77006, encryptionId=1a1de7006b0, topicName=紧急)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b88211514540, createdName=guguangxiang, createdTime=Sat Feb 05 00:24:30 CST 2022, time=2022-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189855, encodeId=4be311898550e, content=未来象感冒一样,每隔一段时间就会再次有感染可能, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Thu Feb 03 10:26:43 CST 2022, time=2022-02-03, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1924221, encodeId=a5b819242219d, content=<a href='/topic/show?id=a37158322eb' target=_blank style='color:#2F92EE;'>#新增病例#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58322, encryptionId=a37158322eb, topicName=新增病例)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/xkicoVBAnV4HxvdCqC1viaW8wdLQdN9hVP9icgqqDsxC6UVPjfhogdfc2iaU1xNUMVlFl5QicicWrjWQBTsVye5ngOQQ/132, createdBy=f92f2500185, createdName=ms7405317358118777, createdTime=Fri Oct 07 20:24:30 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1294653, encodeId=7998129465388, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59218, encryptionId=ca6e592189b, topicName=日本)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Sat Feb 05 00:24:30 CST 2022, time=2022-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342961, encodeId=ae561342961b7, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Sat Feb 05 00:24:30 CST 2022, time=2022-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1414481, encodeId=113414144813e, content=<a href='/topic/show?id=8e95364321f' target=_blank style='color:#2F92EE;'>#南非#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36432, encryptionId=8e95364321f, topicName=南非)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83403055912, createdName=hongbochen, createdTime=Sat Feb 05 00:24:30 CST 2022, time=2022-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1523376, encodeId=687315233e688, content=<a href='/topic/show?id=1a1de7006b0' target=_blank style='color:#2F92EE;'>#紧急#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77006, encryptionId=1a1de7006b0, topicName=紧急)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b88211514540, createdName=guguangxiang, createdTime=Sat Feb 05 00:24:30 CST 2022, time=2022-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189855, encodeId=4be311898550e, content=未来象感冒一样,每隔一段时间就会再次有感染可能, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Thu Feb 03 10:26:43 CST 2022, time=2022-02-03, status=1, ipAttribution=)]
    2022-02-05 hongbochen
  5. [GetPortalCommentsPageByObjectIdResponse(id=1924221, encodeId=a5b819242219d, content=<a href='/topic/show?id=a37158322eb' target=_blank style='color:#2F92EE;'>#新增病例#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58322, encryptionId=a37158322eb, topicName=新增病例)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/xkicoVBAnV4HxvdCqC1viaW8wdLQdN9hVP9icgqqDsxC6UVPjfhogdfc2iaU1xNUMVlFl5QicicWrjWQBTsVye5ngOQQ/132, createdBy=f92f2500185, createdName=ms7405317358118777, createdTime=Fri Oct 07 20:24:30 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1294653, encodeId=7998129465388, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59218, encryptionId=ca6e592189b, topicName=日本)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Sat Feb 05 00:24:30 CST 2022, time=2022-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342961, encodeId=ae561342961b7, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Sat Feb 05 00:24:30 CST 2022, time=2022-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1414481, encodeId=113414144813e, content=<a href='/topic/show?id=8e95364321f' target=_blank style='color:#2F92EE;'>#南非#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36432, encryptionId=8e95364321f, topicName=南非)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83403055912, createdName=hongbochen, createdTime=Sat Feb 05 00:24:30 CST 2022, time=2022-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1523376, encodeId=687315233e688, content=<a href='/topic/show?id=1a1de7006b0' target=_blank style='color:#2F92EE;'>#紧急#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77006, encryptionId=1a1de7006b0, topicName=紧急)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b88211514540, createdName=guguangxiang, createdTime=Sat Feb 05 00:24:30 CST 2022, time=2022-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189855, encodeId=4be311898550e, content=未来象感冒一样,每隔一段时间就会再次有感染可能, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Thu Feb 03 10:26:43 CST 2022, time=2022-02-03, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1924221, encodeId=a5b819242219d, content=<a href='/topic/show?id=a37158322eb' target=_blank style='color:#2F92EE;'>#新增病例#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58322, encryptionId=a37158322eb, topicName=新增病例)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/xkicoVBAnV4HxvdCqC1viaW8wdLQdN9hVP9icgqqDsxC6UVPjfhogdfc2iaU1xNUMVlFl5QicicWrjWQBTsVye5ngOQQ/132, createdBy=f92f2500185, createdName=ms7405317358118777, createdTime=Fri Oct 07 20:24:30 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1294653, encodeId=7998129465388, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59218, encryptionId=ca6e592189b, topicName=日本)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Sat Feb 05 00:24:30 CST 2022, time=2022-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342961, encodeId=ae561342961b7, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Sat Feb 05 00:24:30 CST 2022, time=2022-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1414481, encodeId=113414144813e, content=<a href='/topic/show?id=8e95364321f' target=_blank style='color:#2F92EE;'>#南非#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36432, encryptionId=8e95364321f, topicName=南非)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83403055912, createdName=hongbochen, createdTime=Sat Feb 05 00:24:30 CST 2022, time=2022-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1523376, encodeId=687315233e688, content=<a href='/topic/show?id=1a1de7006b0' target=_blank style='color:#2F92EE;'>#紧急#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77006, encryptionId=1a1de7006b0, topicName=紧急)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b88211514540, createdName=guguangxiang, createdTime=Sat Feb 05 00:24:30 CST 2022, time=2022-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189855, encodeId=4be311898550e, content=未来象感冒一样,每隔一段时间就会再次有感染可能, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Thu Feb 03 10:26:43 CST 2022, time=2022-02-03, status=1, ipAttribution=)]
    2022-02-03 小小医者

    未来象感冒一样,每隔一段时间就会再次有感染可能

    0

相关资讯

2022年1月29日简报:奥密克戎“姐妹株”BA.2传染性翻倍,可能很快成为主流;纽约住院病例大降47%

截至北京时间2022年1月29日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过3亿7016万例,新增3,388,309例,达到370,169

2022年1月30日简报:灭活疫苗加强针可防奥密克戎致重症;欧盟全面推行防疫解封政策;奥密克戎感染病例占单周新冠病例总数的99.9%;

截至北京时间2022年1月30日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过3亿7289万例,新增2,628,337例,达到372,899

2022年1月31日简报:全球关注奥密克戎BA.2亚型,传播速度是BA.1的1.5倍;全球疫情已见顶,欧美主要国家疫情开始消退

截至北京时间2022年1月31日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过3亿7506万例,新增2,112,279例,达到375,060

2022年2月1日简报:奥密克戎BA.2亚型可能较快速度占领全球,毒力如何还有待研究;世界卫生组织认为奥密克戎可能会淹没卫生系统

截至北京时间2022年2月1日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过3亿7746万例,新增1,912,716例,达到377,469,

Nature:奥密克戎会终结新冠全球大流行吗?看看专家怎么说

临床上实际观察到的结果也表明,奥密克戎感染后重症比例较之前的新冠毒株和突变株更低。这表明奥密克戎更为温和,因此有一种声音是奥密克戎的大规模传播有助于终结新冠大流行。

2022年2月2日简报:张文宏认为最坏的日子要慢慢过去啦;美国因新冠死亡人数接近100万,八成是老人;全球因抗击疫情产生了海量医疗垃圾,威胁环境与人类健康

截至北京时间2022年2月2日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过3亿8174万例,新增2,816,336例,达到381,747,